These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36601022)

  • 1. Progesterone Receptor-Mediated Regulation of Cellular Glucose and
    Salem K; Reese RM; Alarid ET; Fowler AM
    J Endocr Soc; 2022 Dec; 7(2):bvac186. PubMed ID: 36601022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and Isoform Specificity of
    Salem K; Kumar M; Yan Y; Jeffery JJ; Kloepping KC; Michel CJ; Powers GL; Mahajan AM; Fowler AM
    J Nucl Med; 2019 Feb; 60(2):220-226. PubMed ID: 30030339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
    Fowler AM; Chan SR; Sharp TL; Fettig NM; Zhou D; Dence CS; Carlson KE; Jeyakumar M; Katzenellenbogen JA; Schreiber RD; Welch MJ
    J Nucl Med; 2012 Jul; 53(7):1119-26. PubMed ID: 22669982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions.
    Mavi A; Cermik TF; Urhan M; Puskulcu H; Basu S; Yu JQ; Zhuang H; Czerniecki B; Alavi A
    J Nucl Med; 2007 Aug; 48(8):1266-72. PubMed ID: 17631558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
    Faivre EJ; Daniel AR; Hillard CJ; Lange CA
    Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating
    Kumar M; Salem K; Jeffery JJ; Yan Y; Mahajan AM; Fowler AM
    J Nucl Med; 2021 Apr; 62(4):500-506. PubMed ID: 32859700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin.
    Nardulli AM; Katzenellenbogen BS
    Endocrinology; 1988 Apr; 122(4):1532-40. PubMed ID: 3345726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
    Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
    Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of
    Nguyen A; Fullard K; Sheehan-Dare G; Tang R; Chan L; Ho B; Dear R; Keane J; Hickey A; Nandurkar R; Chen J; Chen A; Lim E; Emmett L
    J Med Imaging Radiat Oncol; 2022 Sep; 66(6):731-737. PubMed ID: 34676675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells.
    Bamberger AM; Thuneke I; Schulte HM
    Breast Cancer Res Treat; 1998 Jan; 47(2):153-61. PubMed ID: 9497103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.
    Jung KH; Lee EJ; Park JW; Lee JH; Moon SH; Cho YS; Lee KH
    PLoS One; 2019; 14(9):e0221294. PubMed ID: 31532771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-6-phosphatase Expression-Mediated [
    Kim MJ; Lee CH; Lee Y; Youn H; Kang KW; Kwon J; Alavi A; Carlin S; Cheon GJ; Chung JK
    Mol Imaging Biol; 2019 Oct; 21(5):917-925. PubMed ID: 30719695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor.
    Pang Y; Thomas P
    Steroids; 2011 Aug; 76(9):921-8. PubMed ID: 21291899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.
    Shen T; Horwitz KB; Lange CA
    Mol Cell Biol; 2001 Sep; 21(18):6122-31. PubMed ID: 11509655
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.